Topical phenytoin treatment in bimaxillary osteomyelitis secondary to infantile osteopetrosis: report of a case.

J Oral Maxillofac Surg

Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Hacettepe University, Ankara, Turkey.

Published: July 2006

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2005.11.047DOI Listing

Publication Analysis

Top Keywords

topical phenytoin
4
phenytoin treatment
4
treatment bimaxillary
4
bimaxillary osteomyelitis
4
osteomyelitis secondary
4
secondary infantile
4
infantile osteopetrosis
4
osteopetrosis report
4
report case
4
topical
1

Similar Publications

Objective: This study aims to observe the outcomes of topical phenytoin treatment in healing neuropathic diabetic foot ulcers with mild infection and compare these outcomes with those obtained from conventional dressing methods.

Methods: A retrospective observational study was conducted by reviewing the medical records of patients with neuropathic diabetic foot ulcers treated at a tertiary care center from 2015 to 2020. Two groups were identified: (1) patients treated with topical phenytoin (for ulcers measuring less than 5 cm, a dosage of 100 mg was used; for ulcers measuring between 5 cm and 9 cm, a dosage of 150 mg was used; for ulcers measuring between 10 cm and 15 cm, a dosage of 200 mg was used; and for ulcers measuring greater than 15 cm, a dosage of 300 mg was used.

View Article and Find Full Text PDF

Introduction: Severe acne breakouts often lead to atrophic acne scars, which affect millions of people worldwide and can significantly affect a person's self-confidence and self-image. Given the difficulty in treating atrophic acne scars, this study aims to investigate the efficacy of topical phenytoin in the treatment of atrophic acne scars.

Method: This split face clinical trial on 25 patients between the ages of 18 and 40 involved the application of microneedling on one side of the face, with three sessions taking place over the course of a month.

View Article and Find Full Text PDF

Background: Although phenytoin's potential benefits in wound healing, pain relief, and infection control across various wound types have been previously reported, its use in wound care remains limited.

Objective: To conduct a comprehensive review to assess the efficacy of topical phenytoin compared with standard and alternative treatments for different wound types.

Materials And Methods: The authors last searched Cochrane Library, PubMed, PubMed Central, and MEDLINE in June 2023.

View Article and Find Full Text PDF

To examine the effect of topical phosphatidylserine (PS) on wound healing factors and tissue necrosis in in vivo models. Topical PS was applied to evaluate aspects of the wound healing process and growth factors production of vascular endothelial growth factors (VEGF) as well a necrosis reduction in the skin flap of rat models. Moreover, phenytoin (PHT) and cyclosporine A (CsA) were used topically as positive control treatments in wound and necrosis models, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • * The review discusses various innovative treatment options for DFU, including bioactive dressings, stem cell therapies, and repurposed medications, but most evidence is from small, inconsistent clinical trials.
  • * A comprehensive and multi-faceted treatment approach is necessary, as no single method can fully address the complex causes of DFU; further research with larger, well-designed studies is needed.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!